Jacobs Levy Equity Management
TSVT

Jacobs Levy Equity Management’s 2seventy bio TSVT Stock Holding History

Jacobs Levy Equity Management’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-146,315
Closed -$563K – 1050
2024
Q2 		$563K Sell
146,315
-233,271
-61% -$1.05M ﹤0.01% 822
2024
Q1 		$2.03M Buy
+379,586
New +$1.79M 0.01% 595
2023
Q4 		– Sell
-779,529
Closed -$3.06M – 1082
2023
Q3 		$3.06M Buy
779,529
+258,265
+50% +$1.69M 0.02% 478
2023
Q2 		$5.28M Buy
521,264
+405,084
+349% +$4.29M 0.03% 382
2023
Q1 		$1.19M Buy
116,180
+1,065
+0.9% +$12.2K 0.01% 671
2022
Q4 		$1.08M Buy
115,115
+12,047
+12% +$170K 0.01% 668
2022
Q3 		$1.5M Buy
+103,068
New +$1.53M 0.01% 617

Other funds holding TSVT

KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Jacobs Levy Equity Management's TSVT Position: Q3 2024 in Review

Jacobs Levy Equity Management sold out of 2seventy bio (TSVT) in Q3 2024, closing a stake of 146,315 shares — an estimated $563K sold.

Jacobs Levy Equity Management first reported a position in TSVT in Q3 2022 and held it in 7 quarters. The position peaked at $5.28M in Q2 2023. 115 funds tracked by Wall St. Rank hold TSVT as of Q3 2024.

  • Jacobs Levy Equity Management reported no remaining 2seventy bio position as of Q3 2024 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 146,315 2seventy bio shares in Q3 2024, an estimated $563K.
  • Jacobs Levy Equity Management first reported a position in 2seventy bio in Q3 2022 and held it in 7 quarters.
  • Jacobs Levy Equity Management's 2seventy bio position peaked at $5.28M in Q2 2023.
  • 115 funds tracked by Wall St. Rank held 2seventy bio as of Q3 2024.

Based on Jacobs Levy Equity Management's 13F filing for Q3 2024, filed 14 Nov 2024.